ArticlePloS one2025
Incidental extramammary findings on breast magnetic resonance imaging: Prevalence and recommended diagnostic follow-up.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among the current clinical imaging modalities, magnetic resonance imaging (MRI) has the highest sensitivity for breast cancer detection. Only a few studies have been conducted on the extramammary findings of breast MRI; nonetheless, incidental extramammary findings on the breast MR images of the patients are likely to be malignant and may influence staging and treatment. The aim of this study was to assess the prevalence of extramammary findings on breast MRIs and explore the appropriate diagnostic steps. This retrospective study included 234 patients (mean age: 55.8 years) who underwent breast MRI scans at King Abdul-Aziz University Hospital between 2013 and 2020. Reports were reviewed to identify incidental findings, categorized as pathological findings or congenital anomalies. The included patients had confirmed malignant tumors and no prior breast MRI findings. The patient demographics, MRI findings, and indications were recorded. Nineteen incidental extramammary findings were recorded in 16 of the 234 patients with breast cancer whose records were reviewed. The most common sites were the musculoskeletal system (21%), liver (37%), and lungs (21%). Pleural and chest wall involvement was found in two instances (10.5%). One patient (6%) underwent a biopsy, while 15 patients (94%) underwent further imaging. Incidental extra-mammary findings on breast MRI should not be neglected. This study showed that breast MRI examinations were associated with a 7% rate of extramammary findings, suggesting the need for careful evaluation during routine breast MRI. These findings may require further diagnostic evaluation depending on the clinical context. A consistent and systematic diagnostic approach is needed to identify extramammary abnormalities on breast MR scans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.